Intravenous immunoglobulin treatment of the complex regional pain syndrome: A randomized trial

Annals of Internal Medicine

Volumn 152, Issue 3, 2010, Pages 152-158

  Goebel, Andreas ^a   Baranowski, Andrew ^b   Maurer, Konrad ^c   Ghiai, Artemis ^b   McCabe, Candy ^d   Ambler, Gareth ^e  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d ROYAL NATIONAL HOSPITAL FOR RHEUMATIC DISEASES   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; PARACETAMOL; PLACEBO; SANDOGLOBULIN NF; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADULT; ANALGESIA; ARTICLE; BRIEF PAIN INVENTORY; CHILL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPLEX REGIONAL PAIN SYNDROME; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEPRESSION; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; ECZEMA; FATIGUE; FEMALE; GINGIVITIS; HUMAN; MALE; NAUSEA; PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UNIVERSITY HOSPITAL;

EID: 75749126204     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-152-3-201002020-00006     Document Type: Article

References (34)

1. de Mos M, de Bruijn AG, Huygen FJ, Dieleman JP, Stricker BH, Sturkenboom MC. The incidence of complex regional pain syndrome: a populationbased study. Pain. 2007;129:12-20. [PMID: 17084977]
2. McCabe CS, Haigh RC, Ring EF, Halligan PW, Wall PD, Blake DR. A controlled pilot study of the utility of mirror visual feedback in the treatment of complex regional pain syndrome (type 1). Rheumatology (Oxford). 2003;42:97-101. [PMID: 12509620]
3. Oerlemans HM, Oostendorp RA, de Boo T, Goris RJ. Pain and reduced mobility in complex regional pain syndrome I: outcome of a prospective randomised controlled clinical trial of adjuvant physical therapy versus occupational therapy. Pain. 1999;83:77-83. [PMID: 10506674]
4. Kingery WS. A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain. 1997;73:123-39. [PMID: 9415498]
5. Veldman PH, Reynen HM, Arntz IE, Goris RJ. Signs and symptoms of reflex sympathetic dystrophy: prospective study of 829 patients. Lancet. 1993;342: 1012-6. [PMID: 8105263]
6. Rowbotham MC. Pharmacologic management of complex regional pain syndrome. Clin J Pain. 2006;22:425-9. [PMID: 16772796]
7. Forouzanfar T, Köke AJ, van Kleef M, Weber WE. Treatment of complex regional pain syndrome type I. Eur J Pain. 2002;6:105-22. [PMID: 11900471]
8. Huygen FJ, De Bruijn AG, De Bruin MT, Groeneweg JG, Klein J, Zijlstra FJ. Evidence for local inflammation in complex regional pain syndrome type 1. Mediators Inflamm. 2002;11:47-51. [PMID: 11930962]
9. Uçeyler N, Eberle T, Rolke R, Birklein F, Sommer C. Differential expression patterns of cytokines in complex regional pain syndrome. Pain. 2007;132:195-205. [PMID: 17890011]
10. Alexander GM, van Rijn MA, van Hilten JJ, Perreault MJ, Schwartzman RJ. Changes in cerebrospinal fluid levels of pro-inflammatory cytokines in CRPS. Pain. 2005;116:213-9. [PMID: 15964681]
11. Goebel A, Netal S, Schedel R, Sprotte G. Human pooled immunoglobulin in the treatment of chronic pain syndromes. Pain Med. 2002;3:119-27. [PMID: 15102158]
12. Goebel A, Stock M, Deacon R, Sprotte G, Vincent A. Intravenous immunoglobulin response and evidence for pathogenic antibodies in a case of complex regional pain syndrome 1 [Letter]. Ann Neurol. 2005;57:463-4. [PMID: 15732112]
13. Blaes F, Tschernatsch M, Braeu ME, Matz O, Schmitz K, Nascimento D, et al. Autoimmunity in complex-regional pain syndrome. Ann N Y Acad Sci. 2007;1107:168-73. [PMID: 17804544]
14. Harden RN, Bruehl S, Stanton-Hicks M, Wilson PR. Proposed new diagnostic criteria for complex regional pain syndrome. Pain Med. 2007;8:326-31. [PMID: 17610454]
15. Cleeland CS. Measurement of pain by subjective report. In: Chapman CR, Loeser JD, eds. Issues in Pain Management. New York: Raven; 1989:391-403.
16. Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point pain rating scale. Pain. 2001;94:149-58. [PMID: 11690728]
17. European Union. International Conference of Harmonisation Topic E6(R1), Guideline for Good Clinical Practice: European Medicines Agency 2006. (Note for Guidance on Good Clinical Practice, CPMP/ICH/135/95). EU Directive 2006.
18. Price DD, Long S, Wilsey B, Rafii A. Analysis of peak magnitude and duration of analgesia produced by local anesthetics injected into sympathetic ganglia of complex regional pain syndrome patients. Clin J Pain. 1998;14:216-26. [PMID: 9758071]
19. Rauck RL, Eisenach JC, Jackson K, Young LD, Southern J. Epidural clonidine treatment for refractory reflex sympathetic dystrophy. Anesthesiology. 1993;79:1163-9; discussion 27A. [PMID: 8267190]
20. Sigtermans MJ, van Hilten JJ, Bauer MC, Arbous MS, Marinus J, Sarton EY, et al. Ketamine produces effective and long-term pain relief in patients with complex regional pain syndrome type 1. Pain. 2009;145:304-11. [PMID: 19604642]
21. Kemler MA, Barendse GA, van Kleef M, de Vet HC, Rijks CP, Furnée CA, et al. Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. N Engl J Med. 2000;343:618-24. [PMID: 10965008]
22. Moseley GL. Graded motor imagery is effective for long-standing complex regional pain syndrome: a randomised controlled trial. Pain. 2004;108:192-8. [PMID: 15109523]
23. Wasner G, Schattschneider J, Binder A, Baron R. Complex regional pain syndrome-diagnostic, mechanisms, CNS involvement and therapy. Spinal Cord. 2003;41:61-75. [PMID: 12595868]
24. Birklein F. Complex regional pain syndrome. J Neurol. 2005;252:131-8. [PMID: 15729516]
25. Maihöfner C, Handwerker HO, Neundörfer B, Birklein F. Patterns of cortical reorganization in complex regional pain syndrome. Neurology. 2003;61: 1707-15. [PMID: 14694034]
26. Moalem G, Tracey DJ. Immune and inflammatory mechanisms in neuropathic pain. Brain Res Rev. 2006;51:240-64. [PMID: 16388853]
27. DeLeo JA, Yezierski RP. The role of neuroinflammation and neuroimmune activation in persistent pain. Pain. 2001;90:1-6. [PMID: 11166964]
28. Arruda JL, Sweitzer S, Rutkowski MD, DeLeo JA. Intrathecal anti-IL-6 antibody and IgG attenuates peripheral nerve injury-induced mechanical allodynia in the rat: possible immune modulation in neuropathic pain. Brain Res. 2000;879:216-25. [PMID: 11011025]
29. Goebel A, Vogel H, Caneris O, Bajwa Z, Clover L, Roewer N, et al. Immune responses to Campylobacter and serum autoantibodies in patients with complex regional pain syndrome. J Neuroimmunol. 2005;162:184-9. [PMID: 15833374]
30. Blaes F, Schmitz K, Tschernatsch M, Kaps M, Krasenbrink I, Hempelmann G, et al. Autoimmune etiology of complex regional pain syndrome (M. Sudeck). Neurology. 2004;63:1734-6. [PMID: 15534271]
31. Kohr D, Tschernatsch M, Schmitz K, Singh P, Kaps M, Schäfer KH, et al. Autoantibodies in complex regional pain syndrome bind to a differentiationdependent neuronal surface autoantigen. Pain. 2009;143:246-51. [PMID: 19375222]
32. de Mos M, Huygen FJ, van der Hoeven-Borgman M, Dieleman JP, Ch Stricker BH, Sturkenboom MC. Outcome of the complex regional pain syndrome. Clin J Pain. 2009;25:590-7. [PMID: 19692800]
33. Moore RA, Gavaghan D, Tramèr MR, Collins SL, McQuay HJ. Size is everything-large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects. Pain. 1998;78: 209-16. [PMID: 9870574]
34. Stangel M, Hartung HP, Marx P, Gold R. Side effects of high-dose intravenous immunoglobulins. Clin Neuropharmacol. 1997;20:385-93. [PMID: 9331514]